###begin article-title 0
A genome-wide synthetic dosage lethality screen reveals multiple pathways that require the functioning of ubiquitin-binding proteins Rad23 and Dsk2
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Ubiquitin regulates a myriad of important cellular processes through covalent attachment to its substrates. A classic role for ubiquitin is to flag proteins for destruction by the proteasome. Recent studies indicate that ubiquitin-binding proteins (e.g. Rad23, Dsk2, Rpn10) play a pivotal role in transferring ubiquitylated proteins to the proteasome. However, the specific role of these ubiquitin receptors remains poorly defined. A key to unraveling the functions of these ubiquitin receptors is to identify their cellular substrates and biological circuits they are involved in. Although many strategies have been developed for substrate isolation, the identification of physiological targets of proteolytic pathways has proven to be quite challenging.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 61 66 <span type="species:ncbi:4932">yeast</span>
Using a genome-wide functional screen, we have identified 11 yeast genes that cause slower growth upon their overexpression in cells lacking two ubiquitin-binding proteins Rad23 and Dsk2. Our results suggest that proper functioning of Rad23 and Dsk2 is required for efficient pheromone response, transcription, amino acid metabolism, and DNA damage response. Two proteins identified by the screen are shown to be proteolytic substrates of Dsk2, validating the large scale synthetic dosage lethality screen as a new strategy for identifying substrates of a specific degradation pathway.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
In conclusion, as proof-of-concept, we show that a synthetic dosage lethality screen, which is based on the toxicity induced by gene overexpression, offers an effective, complementary method to elucidating biological functions of proteolytic pathways.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 253 254 253 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 445 446 445 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 713 714 713 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 764 772 764 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 797 798 797 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
In eukaryotes, the 26S proteasome handles the majority of regulated proteolysis and is pivotal for the proper function of the cell [1,2]. Most proteins that are targeted to the proteasome for degradation are first modified by the ubiquitin (Ub) system [3]. Specifically, successive Ub molecules join to form a Ub chain on the substrates. How the ubiquitylated substrate is then delivered to and degraded by the 26S proteasome remains elusive [2,4-6]. It is now widely accepted that Ub-binding proteins (e.g. Rad23, Rpn10, and Cdc48) play important roles in facilitating substrate transfer to the proteasome. These proteins have distinct substrate specificity and functionally cooperate for substrate proteolysis [7-9]. However, how any one of these proteins works in vivo remains largely unknown [2,6].
###end p 9
###begin p 10
###xml 93 95 93 95 <underline xmlns:xlink="http://www.w3.org/1999/xlink">Ub</underline>
###xml 96 97 96 97 <underline xmlns:xlink="http://www.w3.org/1999/xlink">l</underline>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 116 117 116 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 118 119 118 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 178 186 178 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 190 199 190 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 390 414 390 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 550 564 550 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 656 659 656 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 671 673 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 674 676 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 710 711 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 738 740 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 763 764 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 854 856 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 865 867 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 899 901 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1007 1028 1004 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 1133 1139 1122 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 1143 1148 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2 </italic>
###xml 1273 1275 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1276 1278 1265 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 384 389 <span type="species:ncbi:4932">yeast</span>
###xml 390 414 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 550 563 <span type="species:ncbi:4932">S. cerevisiae</span>
Rad23 belongs to a family of proteins that contain both the Ub-associated (UBA) domain and a Ub-like (UBL) motif [2,4-6]. The UBA motif binds specifically to Ub chain/conjugates in vivo and in vitro [10-12]. The UBL motif directly binds the proteasome [13,14]. Through these domain-mediated interactions, UBA/UBL proteins link ubiquitylated proteins to the proteasome. In the budding yeast Saccharomyces cerevisiae, there are three UBA/UBL-containing proteins, Rad23, Dsk2 and Ddi1, which have been implicated in Ub-mediated proteolysis. The loss of S. cerevisiae Rad23 and Dsk2 leads to the stabilization of an artificially designed Ub-fusion substrate UbV76-V-betagal [12,15], the cell cycle inhibitor Far1 [7], misfolded protein CPY* [16], an ER protein Hmg2 [8], and the homologues of Rad23 are involved in the degradation of the CDK inhibitor Rum1 [11], Pax3 [17] and the tumor suppressor p53 [18]. Consistent with the role of Rad23 and Dsk2 in post-ubiquitylation events, the stabilized substrates in rad23Delta dsk2Delta mutant cells are fully ubiquitylated. Rad23 and Dsk2 play overlapping functions since cells lacking both RAD23 and DSK2 are more sensitive to various stress conditions (e.g., higher temperature, canavanine, high salt) than either single mutant [19,20]. However, the biological pathways that require the functioning of Rad23 and Dsk2 remain to be identified.
###end p 10
###begin p 11
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 792 798 792 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RPN10 </italic>
###xml 799 801 799 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 802 804 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
Not all proteolytic substrates are degraded by the Rad23/Dsk2-dependent pathway. Other Ub-binding proteins, Rpn10, Rpn13, and the Cdc48-Ufd1-Npl4 complex also promote proteasome-mediated proteolysis and exhibit distinct substrate specificity [5,7-9,21]. For example, the cell cycle protein Clb2 requires Rpn10, but not Rad23 for its degradation. And Deg1-GFP is degraded by the Cdc48/Ufd1 pathway, independent of Rpn10 and Rad23. The principle underlying the division of labor among these Ub-binding proteins is far from clear. A key to unraveling the functions of these Ub receptors (e.g. Rad23, Rpn10) is to identify their cellular substrates and biological functions. For example, using mass spectrometry, more than 50 proteins were shown to be preferentially accumulated in cells lacking RPN10 [22,23]. These putative Rpn10 substrates are involved in cell cycle control, protein transport, metabolism, and transcription.
###end p 11
###begin p 12
###xml 116 137 116 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 346 367 338 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
Here, we employ a new method to identify the biological function of Rad23 and Dsk2. The lack of overt phenotypes in rad23Delta dsk2Delta mutant cells likely reflects that redundant pathways are employed in buffering against mutations. Using a synthetic enhancement approach, we have isolated 11 genes that when overexpressed cause slow growth in rad23Delta dsk2Delta mutants. Our data expand the physiological processes that involve Rad23 and Dsk2. Furthermore, we show that two of the encoded proteins isolated by this method are ubiquitylated and degraded by the Dsk2-dependent pathway. Our results also suggest that the synthetic dosage lethality screen can be used to isolate physiological targets of a specific proteolytic pathway.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Strains, media and plasmids
###end title 14
###begin p 15
###xml 255 317 255 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT ura3::natR can1::STE2pr-Sp_his5 lyp1 his3 1 leu2 0 met15 0</italic>
###xml 332 353 332 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 354 377 346 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23::kanMX dsk2::natR</italic>
###xml 437 443 429 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 447 451 439 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2</italic>
###xml 467 470 459 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mat</italic>
###xml 470 472 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a </italic>
###xml 470 472 462 464 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a </italic></bold>
###xml 472 496 464 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lys2 ura3 trp1 his3 leu2</italic>
###xml 505 516 497 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBR1::HIS3 </italic>
###xml 540 547 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ufd1-1 </italic>
###xml 624 626 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 653 663 645 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916;</italic>
###xml 665 674 653 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dsk2&#916;</italic>
###xml 676 721 660 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ddi1&#916;, rpn10&#916;, rpn13&#916;, kre22&#916;</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast cultures were grown in rich (YPD) or synthetic media containing standard ingredients and 2% glucose (SD medium), 2% raffinose (SR medium), or 2% raffinose + 2% galactose (SRG medium). The synthetic genetic array (SGA) compatible S288c strain Y8835 (MAT ura3::natR can1::STE2pr-Sp_his5 lyp1 his3 1 leu2 0 met15 0) and isogenic rad23Delta dsk2Delta (rad23::kanMX dsk2::natR) cells were used for all assays involving the deletions of RAD23 and DSK2. Strains JD52 (Mata lys2 ura3 trp1 his3 leu2), JD55 (UBR1::HIS3 in JD52 background) and ufd1-1 were obtained from Dr. Alex Varshavsky (California Institute of Technology) [24]. Haploid strains bearing rad23Delta, dsk2Delta, ddi1Delta, rpn10Delta, rpn13Delta, kre22Delta, in the BY4741 background were obtained from Open Biosystems (Huntsville, AL, USA).
###end p 15
###begin p 16
###xml 123 128 <span type="species:ncbi:4932">yeast</span>
For the Synthetic Dosage Lethality (SDL) screens, haploids were selected on synthetic dextrose medium (2% glucose; 1.7 g/L yeast nitrogen base w/o ammonium sulfate and amino acids; 1 g/L monosodium glutamic acid; 2 g/L amino acid dropout mix lacking uracil, arginine, lysine and histidine), supplemented with the following antibiotics 100 mg/L clonNAT (Werner BioAgents Jena Germany), 200 mg/L geneticin (Invitrogen, Carlsbad, CA, USA), 50 mg/L L-canavanine (Sigma, St. Louis, MO, USA) and 50 mg/L S-(2-Aminoethyl)-L-cysteine hydrochloride (Sigma).
###end p 16
###begin p 17
###xml 75 78 72 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 142 144 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 145 147 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 195 200 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 384 386 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 387 389 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 257 262 <span type="species:ncbi:4932">yeast</span>
The plasmids expressing the proteasomal substrates Arg-betagal, Scc1, or UbV76-V-betagal, Ricin A chain (RTA) have been previously described [24-26] and substrate expression are regulated by the GAL1 promoter. The pEGH plasmids, which contain an individual yeast gene tagged with both Glutathione S-transferase (GST) protein and His6 at its amino-terminus, were previously described [27,28]. The movable ORF (MORF) clones were purchased from Open Biosystems (Huntsville, AL, USA). The plasmid expressing Ha-Ub was obtained from Dr. Mary Ann Osley (University of New Mexico, Albuquerque, NM, USA).
###end p 17
###begin title 18
Genome-wide synthetic dosage lethal screen
###end title 18
###begin p 19
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3</italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 201 221 201 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916;</italic>
###xml 416 418 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 419 421 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 932 953 924 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 248 253 <span type="species:ncbi:4932">yeast</span>
The URA3-marked overexpression library and the screening procedures used in this study were previously described [28]. Briefly, two isogenic synthetic genetic array (SGA)-compatible strains, Y8835 and rad23Delta dsk2Delta, were mated to an ordered yeast array expressing 5200 unique galactose-inducible genes. The arrayed strains were subjected to diploid selection, sporulation and two rounds of haploid selection [28-30], to give rise to an output array of duplicated colonies carrying the desirable natR-marked deletion and one unique galactose-inducible gene. The haploid arrays were finally replica-pinned onto media containing 2% glucose (uninduced condition) or 2% galactose (induced gene expression condition). The colonies on the glucose and galactose plates were photographed after two and three days of incubation, respectively. Overexpressed genes that uniquely caused a reduction in colony size of more than 20% in the rad23Delta dsk2Delta background were considered for downstream analysis.
###end p 19
###begin title 20
Expression shut-off assay and proteasome inhibition treatment
###end title 20
###begin p 21
###xml 102 107 102 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 149 153 143 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 799 803 <span type="species:ncbi:9925">goat</span>
###xml 809 814 <span type="species:ncbi:10090">mouse</span>
###xml 815 826 <span type="species:ncbi:3704">Horseradish</span>
Yeast cells carrying plasmids expressing hexahistidine (His6) and GST double-tagged proteins from the GAL1 promoter were grown at 30degreesC to an OD600 of approximately 1 in SR-ura medium with auxotrophic supplements and 2% raffinose as the carbon source. Protein expression was induced with 2% galactose for 3 h and then repressed by the addition of 2% glucose. Cycloheximide (100 mug/ml) was also added to stop translation. Samples were withdrawn at the indicated time points and harvested by centrifugation. Proteins were extracted by glass bead lysis of cells, processed for immunoprecipitation with Glutathione sepharose beads (GE-Healthcare, Piscataway, NJ, USA), and resolved by 10% SDS-PAGE. Immunoblots were probed with anti-His6 antibody (Abcam, Cambridge, UK) followed by detection with goat anti-mouse Horseradish Peroxidase (HRP) conjugate using Chemiluminescent reagents (GE-Healthcare). The stable protein Rpt5 was used as a loading control in the expression shutoff experiments.
###end p 21
###begin p 22
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 64 69 <span type="species:ncbi:4932">yeast</span>
Proteasome inhibition was performed as described [31]. Briefly, yeast cells were grown in synthetic media using proline as the only nitrogen source. SDS (0.003%) was added to the media 3 h before galactose induction. MG132 (75 muM; Biomol) was added 30 min before the addition of glucose. Samples were collected at indicated time points and processed as described above.
###end p 22
###begin title 23
Detection of ubiquitylated substrates
###end title 23
###begin p 24
###xml 132 136 132 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600 </sub>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 461 466 <span type="species:ncbi:10090">mouse</span>
Yeast cells expressing GST-tagged substrates and Ha-tagged Ub or myc-tagged Ub were grown in galactose-containing SG medium to an OD600 of approximately 1. Cells were lysed with glass beads and immunoprecipitated with Glutathione sepharose beads for 2 h at 4degreesC. The immunoprecipitates were resolved by SDS-PAGE, transferred to Polyvinylidene fluoride (PVDF) membrane, and immunoblotted with anti-Ha antibody (Covance, Berkeley, CA, USA), followed by anti-mouse HRP conjugates and ECL reagents.
###end p 24
###begin title 25
Results
###end title 25
###begin title 26
Accumulation of proteasomal substrates in degradation mutants can lead to growth retardation
###end title 26
###begin p 27
###xml 530 537 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
We set out to look for physiological substrates of Rad23 and Dsk2. Many strategies have been developed in the past to isolate the substrates of a particular Ub/proteasome pathway with varying degrees of success. Most of these methods explore the facts that substrates directly bind to the degradation machinery and/or substrates are ubiquitylated. Two challenges often encountered in these endeavors are the transient nature of the interaction between substrates and degradation components, and low levels of substrate expression in vivo.
###end p 27
###begin p 28
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">apc </italic>
###xml 548 554 548 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cdc34 </italic>
###xml 562 567 562 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubr1 </italic>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 747 757 747 753 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubr1&#916; </italic>
###xml 845 850 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBR1 </italic>
###xml 898 900 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
To identify the physiological functions of Rad23 and Dsk2, we employed a synthetic dosage lethality screen [32,33]. The premise of SDL is that increased levels of a protein have little toxic effect on the growth of a wild-type strain but may cause growth retardation or even lethality in a mutant strain. Previous studies suggest that this strategy can be adapted to isolate substrates of the Ub/proteasome system. For example, overexpression of several cell cycle proteins (e.g., Clb2, Sic1, Scc1) in proteolysis-deficient cells (e.g. apc mutant, cdc34 mutant, ubr1 mutant) led to extremely slow cell growth (Figure 1A and references [24,34,35]). The growth defect induced by substrate Scc1 overexpression is particularly striking in the case of ubr1Delta cells lacking the E3 enzyme of the N-end rule degradation pathway, since the absence of UBR1 alone does not significantly alter cell growth [36].
###end p 28
###begin p 29
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Accumulation of some proteasomal substrates leads to slower cell growth</bold>
###xml 73 77 73 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 134 144 131 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubr1&#916; </italic>
###xml 290 300 280 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ubr1&#916; </italic>
###xml 396 401 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 753 757 733 737 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 797 800 777 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 816 827 793 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
###xml 913 914 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 433 438 <span type="species:ncbi:4932">yeast</span>
Accumulation of some proteasomal substrates leads to slower cell growth. (A) Compromised degradation of Scc1, but not Arg-betagal, in ubr1Delta mutant cells causes toxicity. The plasmids bearing the N-end rule substrate Arg-betagal or Scc1 were separately introduced into wild-type JD52 or ubr1Delta cells as indicated. The expression of these substrates are regulated by the galactose-inducible GAL1 promoter. Exponentially growing yeast cells were spotted onto glucose-containing SD-ura (expression off) and galactose-containing SG-ura (expression on) media in serial five-fold dilutions. The plates were incubated at 30degreesC for two to four days. The substrates used are labeled on the left of the panel, and the strains are labeled on the right. (B) Increased levels of the UFD substrate UbV76-Val-betagal in rad23 dsk2 mutant cells do not affect cell growth. The spotting experiments were performed as in A.
###end p 29
###begin p 30
###xml 338 346 332 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 384 386 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 401 406 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UBR1 </italic>
###xml 490 492 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 591 594 582 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 635 656 623 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 672 674 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 677 679 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 338 345 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
We then wondered whether the toxicity might be related to the physiological functions of the substrates. In other words, would accumulation of large amounts of any substrate lead to growth retardation in proteolysis-deficient cells? We used an artificially designed N-end rule substrate Arg-betagal, which contains betagalactosidase from E. coli fused to a destabilizing residue Arg [37]. Deletion of UBR1 leads to the accumulation of Arg-betagal, which does not affect cell growth (Figure 1A). Similarly, we found that compromised degradation of another model substrate of the proteasome UbV76-Val-betagal does not elicit toxicity in rad23Delta dsk2Delta mutants (Figure 1B) [12], indicating that the toxicity triggered by substrate accumulation may depend on the physiological function of the target protein. These results further suggest that the SDL screen can identify a subset of substrates of a given proteolytic pathway.
###end p 30
###begin title 31
###xml 18 23 <span type="species:ncbi:4932">yeast</span>
Identification of yeast genes which cause slower growth in rad23 dsk2 mutant cells upon overexpression
###end title 31
###begin p 32
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 199 220 199 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 234 236 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 237 239 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 282 303 274 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 377 382 361 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 680 682 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 916 937 894 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 1006 1007 976 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 88 93 <span type="species:ncbi:4932">yeast</span>
###xml 338 343 <span type="species:ncbi:4932">yeast</span>
The genome-wide SDL screen was carried out as previously described [28]. More than 5000 yeast genes fused to both glutathione S-transferase and His6 tags were separately introduced into wild-type or rad23Delta dsk2Delta mutant cells [28,29]. We compared the growth of wild type vs. rad23Delta dsk2Delta cells that expressed each of these yeast genes from a strong, regulatable GAL1 promoter. The expression of these genes was repressed in glucose containing media, but induced in galactose-containing media. Haploids carrying these plasmids were pinned onto both SD (glucose media) and SG (galactose media) plates. Following incubation for two to three days at 30degreesC (Figure 2A), the colony sizes of these plates were scored using a program developed in Dr. Boone's Lab (University of Toronto, Ontario, Canada). Upon their overexpression, a total of 41 genes were found to preferentially cause slower growth in rad23Delta dsk2Delta mutant cells. Sic1 and Far1, two known substrates of Rad23 and Dsk2 [7], were not isolated as positives in our screen because their overexpression leads to severe toxicity even in wild-type cells (data not shown), suggesting that genes, which severely reduce growth rate in wild-type cells may not be recovered in this type of SDL screen.
###end p 32
###begin p 33
###xml 72 83 72 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of yeast genes that cause stronger growth retardation in <italic>rad23 dsk2 </italic>mutant cells than in wild-type cells</bold>
###xml 121 125 121 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 322 343 322 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 668 676 660 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YLL030C </italic>
###xml 762 766 754 758 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 836 857 828 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 18 23 <span type="species:ncbi:4932">yeast</span>
###xml 210 215 <span type="species:ncbi:4932">yeast</span>
Identification of yeast genes that cause stronger growth retardation in rad23 dsk2 mutant cells than in wild-type cells. (A) Representative images from plasmid overexpression screen. Each of approximately 5280 yeast ORFs regulated by a galactose inducible Gal1 promoter was transformed separately into wild-type Y8835 and rad23Delta dsk2Delta mutant cells. Transformants were grown on media containing either glucose (SD, expression off) or galactose (SG, expression on). Each ORF is represented by two spots on the plate to reduce false positives. After two days for SD plates and three days for SG plates, colony sizes were scored for possible hits. Boxed spots are YLL030C on each plate. Strains and growth conditions are labeled at the bottom of each image. (B) A spotting assay indicates 11 genes cause preferential slow growth in rad23Delta dsk2Delta mutant cells. The spotting assay was conducted as described in Figure 1A. The identities of these genes and the corresponding strains are listed to the left and right of the panels, respectively.
###end p 33
###begin p 34
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 407 428 407 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 508 513 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 581 584 573 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 690 711 682 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 789 791 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 974 976 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
As is common in nearly all screens, we expected our approach to yield false positives, especially since a low cut-off (20% difference in colony size) is used to define a hit. The 20% cut-off ensures that most of the toxic genes are efficiently captured in our screens (Figure 2A). To eliminate false hits, we performed a serial spotting assay with each candidate identified. More specifically, wild-type or rad23Delta dsk2Delta mutant cells containing the candidate open reading frame (ORF) regulated by the GAL1 promoter were grown in non-inducible raffinose media to a similar OD600, and then spotted onto SD and SG plates in five-fold serial dilutions. The growth rates of wild-type and rad23Delta dsk2Delta mutant cells bearing a vector plasmid are similar under the condition (Figure 2B). Of the 41 genes identified in the primary screen, eleven genes were confirmed to cause noticeably slower growth in mutant cells than in wild-type cells upon overexpression (Figure 2B).
###end p 34
###begin p 35
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YLL030C</italic>
###xml 44 51 44 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YLR241W</italic>
###xml 173 187 173 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces </italic>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAD10 </italic>
###xml 629 631 629 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 677 679 677 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 783 785 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 977 982 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DTR1 </italic>
###xml 1150 1152 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1196 1217 1193 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 1262 1264 1251 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1360 1362 1349 1351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Whereas two identified genes (i.e. YLL030C, YLR241W) have not been functionally characterized, the other nine genes are involved in a variety of cellular processes (see the Saccharomyces Genome Database yeastgenome.org and the YPD database ). AAD10 encodes an aryl alcohol dehydrogenase important for amino acid catabolism. Mss11 and Rfx1 are transcription factors involved in the regulation of invasive growth and in DNA damage responses, respectively. Ppg1 has protein phosphatase activity and is involved in glycogen accumulation. Systematic deletion studies suggest that Kre22 (Ydr433w) is involved in glycogen accumulation [38], mitochondrial distribution and morphology [39], and is important in resistance to DNA damaging agents (e.g. hydroxyurea, UV and ionizing radiation) [40]. Vph1 is a subunit of the vacuolar H(+)-ATPase essential for vacuolar acidification. Ste4 functions as the beta subunit of the G protein that mediates pheromone-induced signal transduction. DTR1 encodes the dityrosine transporter involved in the maturation of the spore wall. It is worth noting that overexpression of Spc98, a component of the spindle pole body [41], causes more severe growth retardation in rad23Delta dsk2Delta mutant cells than in wild-type cells (Figure 2B), consistent with previous findings that suggest a role of Rad23 and Dsk2 in spindle function [19].
###end p 35
###begin title 36
The degradation of Kre22 and YLL030C requires Rad23/Dsk2
###end title 36
###begin p 37
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 402 407 402 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2 </italic>
###xml 415 420 415 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A, B</xref>
###xml 496 502 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2 </italic>
As reasoned above, accumulation of a large amount of substrates can lead to toxicity in cells defective in proteolysis (Figure 1A). We examined the stability of the proteins encoded by the eleven isolated genes in wild-type or mutant cells by an expression shut-off assay. Two proteins, Kre22 and YLL030C are rapidly degraded in wild-type cells, but significantly stabilized in cells lacking RAD23 and DSK2 (Figure 3A, B), suggesting that they are degraded by the Rad23/Dsk2 pathway. Deletion of RAD23 and DSK2 does not significantly alter the half-life of the other nine proteins identified by our screen (data not shown).
###end p 37
###begin p 38
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kre22 and YLL030C are degraded by a Rad23/Dsk2-dependent pathway</bold>
###xml 66 72 66 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-B) </bold>
###xml 134 140 134 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 695 701 695 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C-D) </bold>
###xml 805 815 805 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ufd2&#916; </italic>
###xml 891 892 887 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 894 898 890 894 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 1376 1378 1372 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1381 1387 1377 1383 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F-G) </bold>
###xml 1485 1491 1481 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23 </italic>
###xml 1495 1499 1491 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2</italic>
###xml 1628 1649 1624 1637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 1693 1694 1681 1682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
Kre22 and YLL030C are degraded by a Rad23/Dsk2-dependent pathway. (A-B) Degradation of Kre22 and YLL030C is impaired in cells lacking RAD23 and DSK2. Wild-type (Y8835) and mutant cells containing a GAL1 promoter regulated GST and His6 tagged Kre22 or YLL030C were first grown in raffinose-containing media. Protein expression was then induced by the addition of galactose. Samples were taken after expression shutoff at intervals, processed for immunoprecipitation with GST beads, and analyzed by Western blotting using anti-His6 antibody. Equal amounts of protein extracts were used and confirmed by blotting with anti-Rpt5 antibody in all of the expression shutoff experiments (lower panels). (C-D) Degradation of Kre22 and YLL030C is Ufd2-independent. The stability of Kre22 or YLL030C in wild-type or ufd2Delta mutant cells was determined by an expression shut-off assay as described in A. (E) Kre22 and YLL030C are not glycosylated. GST-tagged Kre22 or YLL030C was expressed in wild-type cells and recovered by immunoprecipitation. The immunoprecipitates were mock treated (-) or digested (+) with Endoglycosidase H (Endo H), resolved by SDS-PAGE, and visualized by immunoblotting. If the proteins are N-glycosylated, the bands are expected to migrate faster on the gel after Endo H treatment. A positive control for EndoH treatment of RTA is also included on the right [26]. (F-G) Degradation of Kre22 and YLL030C appended with other epitope tags is compromised in cells lacking RAD23 and DSK2. The stability of Kre22 or YLL030C tagged with C-terminal Ha epitope and the IgG-binding domain from protein A in wild-type and rad23Delta dsk2Delta mutant cells was determined as described in A, except the immunoprecipitation was done with IgG sepharose and the blots were probed with anti-Ha antibody.
###end p 38
###begin p 39
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 343 348 343 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C, D</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
Previously, we demonstrated that Rad23 works with two different co-factors Ufd2 (a Ub chain elongation factor, E4) and Png1 (a deglycosylation enzyme) to degrade distinct substrates [20,26]. Here, we examined whether Kre22 or YLL030C turn-over requires Ufd2 or Png1. Deletion of Ufd2 does not alter the degradation of Kre22 or YLL030C (Figure 3C, D). The Png1-Rad23 complex is involved in degrading glycosylated proteins [26]. We found that neither protein is glycosylated (Figure 3E), suggesting that Kre22 and YLL030C are not Png1 substrates. It is likely that these substrates would require co-factors other than Ufd2 and Png1 for their degradation.
###end p 39
###begin p 40
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 520 525 520 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F, G</xref>
###xml 729 750 729 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
Since these substrates are tagged with GST moiety at their N-terminus, one concern of our results is that the degradation of these proteins may be altered by the GST fusion. To this end, we obtained the MORF plasmids expressing YLL030C and Kre22, which are tagged at their carboxyl-terminus with both His6 and the IgG-binding site from protein A (Open Biosystems) that theoretically could also affect protein degradation. As shown in Figure 3, YLL030C and Kre22 are still degraded in Rad23/Dsk2-dependent manner (Figure 3F, G), suggesting that the involvements of Rad23 and Dsk2 in Kre22 and YLL030C degradation are not due to artifacts caused by GST tags. Overexpression of these MORF plasmids also led to growth retardation in rad23Delta dsk2Delta mutant cells (data not shown).
###end p 40
###begin title 41
Kre22 and YLL030C are ubiquitylated, proteasomal substrates
###end title 41
###begin p 42
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 362 367 362 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
Are these newly identified Rad23/Dsk2 substrates destroyed by the proteasome or some other proteolytic activity (e.g. lysosome)? To assess the involvement of the proteasome in the degradation of Kre22 or YLL030C, we carried out a simple proteasome inhibition assay [31]. We found that the degradation of Kre22 or YLL030C is impaired upon MG132 treatment (Figure 4A, B), suggesting that these proteins are degraded by the proteasome.
###end p 42
###begin p 43
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Ubiquitin and the proteasome are involved in Kre22 and YLL030C degradation</bold>
###xml 76 82 76 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-B) </bold>
###xml 407 411 407 411 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 536 547 536 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
###xml 142 147 <span type="species:ncbi:4932">yeast</span>
###xml 290 295 <span type="species:ncbi:4932">yeast</span>
Ubiquitin and the proteasome are involved in Kre22 and YLL030C degradation. (A-B) Kre22 and YLL030C are degraded by the proteasome. Wild-type yeast cells expressing Kre22 or YLL030C were treated with or without the proteasome inhibitor MG132. To facilitate the uptake of MG132 by wild-type yeast cells, we used L-proline as the nitrogen source in the growth medium and added a small amount of SDS (0.003%). (C) Kre22 and YLL030C are ubiquitylated. GST- and His6-tagged substrates were co-transformed with Ha-tagged Ub into wild-type or rad23 dsk2 mutant cells. Kre22 or YLL030C was precipitated with GST beads and analyzed by immunoblotting first with anti-Ha antibody and later anti-His6 antibody. Ubiquitylated and non-ubiquitylated Kre22 and YLL030C proteins are indicated on two sides of the upper panel. Rpt5 (bottom panel) is used as a loading control.
###end p 43
###begin p 44
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 357 378 357 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 631 633 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 733 734 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 735 736 727 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 792 813 784 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23&#916; dsk2&#916; </italic>
###xml 853 855 837 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
Most, but not all, proteasomal substrates are ubiquitylated. The function of Rad23/Dsk2 in proteolysis requires their UBA domains, which bind to Ub [4]. To determine whether the newly identified substrates are ubiquitylated, we co-transformed the plasmid expressing the GST- and His6-tagged substrate with the plasmid bearing Ha-tagged Ub into wild-type or rad23Delta dsk2Delta mutant cells. GST-tagged substrates were immunoprecipitated from cellular lysates with GST beads, and processed for Western blotting with anti-Ha antibody to detect ubiquitylated substrate. We found that both Kre22 and YLL030C are ubiquitylated (Figure 4C). Consistent with the function of Rad23 and Dsk2 at a pre-proteasome but post-ubiquitylation step [4,5], much more ubiquitylated species were detected in the rad23Delta dsk2Delta mutants than in wild type cells (Figure 4C).
###end p 44
###begin title 45
The involvement of specific Ub receptor for the degradation of Kre22 or YLL030C
###end title 45
###begin p 46
###xml 210 211 210 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 309 310 309 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A-H</xref>
###xml 509 520 509 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B, D, F, H</xref>
###xml 605 616 605 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A, C, E, G</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 728 739 728 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rpn10&#916; </italic>
###xml 777 782 773 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C, D</xref>
###xml 374 379 <span type="species:ncbi:4932">yeast</span>
Ub-binding proteins that function in proteasome-mediated proteolysis include three UBA/UBL proteins (i.e. Rad23, Dsk2, Ddi1), two proteasome-associated factors Rpn10 and Rpn13, and the Ufd1-Cdc48-Npl4 complex [2,21]. These Ub-receptors have different substrates and sometimes carry out overlapping functions [2]. We examined the stability of GST-tagged Kre22 and YLL030C in yeast cells lacking individual Ub receptor (Figure 5A-H). Both Dsk2 and Ufd1 are required for efficient degradation of YLL030C (Figure 5B, D, F, H). Interestingly, Dsk2 is the only Ub receptor involved in Kre22 degradation (Figure 5A, C, E, G). Furthermore, consistent with the restriction of Dsk2 by Rpn10 [42], Kre22 and YLL030C are degraded faster in rpn10Delta cells than in wild-type cells (Figure 5C, D).
###end p 46
###begin p 47
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Kre22 and YLL030C degradation in yeast cells lacking individual Ub receptor</bold>
###xml 77 83 77 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-H) </bold>
###xml 144 182 144 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAD23, DSK2, DDI1, RPN10, RPN13, UFD1 </italic>
###xml 33 38 <span type="species:ncbi:4932">yeast</span>
Kre22 and YLL030C degradation in yeast cells lacking individual Ub receptor. (A-H) Degradation of GST-tagged Kre22 and YLL030C in cells lacking RAD23, DSK2, DDI1, RPN10, RPN13, UFD1 was determined as described in Figure 3A.
###end p 47
###begin title 48
Kre22 overexpression suppresses Dsk2-induced toxicity
###end title 48
###begin p 49
###xml 134 145 134 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A, C, E, G</xref>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 803 804 803 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 805 806 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 807 808 807 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
To our knowledge, Kre22 is the first substrate that requires only Dsk2 but none of the other Ub receptors for its degradation (Figure 5A, C, E, G). Supporting the direct link between Dsk2 and Kre22, we detected the Dsk2-Kre22 interaction by co-immunoprecipitations (Figure 6A). It will be important to determine the specific domains of Dsk2 involved in Kre22-binding and degradation, and the role of ubiquitylation in the Dsk2-Kre22 interaction. Since little is known about Dsk2-specific substrates, we examined the Ub linkage assembled onto Kre22. Lys48- and Lys63-linked chains were recently linked to the Dsk2 pathway [42]. Specifically, we employed Ub mutants (i.e. Lys48Arg, Lys63Arg) that had either Lys48 or Lys63 replaced with Arg, which in turn blocked Ub conjugation to these lysine residues [2,3,6]. We found that Kre22 ubiquitylation was abolished by Lys48Arg mutation (Figure 6B), suggesting that the Ub chain attached to Kre22 contained Lys48 linkage.
###end p 49
###begin p 50
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The interactions between Kre22 and Dsk2</bold>
###xml 41 45 41 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 611 615 611 615 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 991 995 991 995 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1011 1017 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRE22 </italic>
###xml 1032 1036 1032 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2</italic>
###xml 1148 1153 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2 </italic>
###xml 1190 1195 1190 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 1248 1259 1248 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kre22&#916; </italic>
###xml 1555 1559 1551 1555 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 1577 1582 1573 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KRE22</italic>
###xml 1635 1638 1631 1634 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 1661 1665 1654 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2</italic>
###xml 1814 1819 1807 1812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1 </italic>
###xml 1884 1889 1877 1882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DSK2 </italic>
###xml 1301 1306 <span type="species:ncbi:4932">yeast</span>
The interactions between Kre22 and Dsk2. (A) Kre22 binds Dsk2. Co-immunoprecipitation analysis of the interaction between GST-His6-tagged Kre22 and Dsk2-TAP was done as previously described [20]. Briefly, proteins were extracted from cells expressing endogenous Dsk2-TAP and galactose-inducible GST-His6-tagged Kre22 and immunoprecipitated with either IgG or GST-beads as indicated on the left. Immunoprecipitates were resolved by SDS-PAGE and probed with indicated antibodies. The identity of the bands is indicated on the right. The antibodies for IP and immuno-blot (IB) are shown to the left of the panels. (B) Kre22 ubiquitylation involves Lys48-linked Ub chains. GST-His6-tagged Kre22 was co-transformed with myc-tagged wild-type or mutant Ub into wild-type cells. Kre22 was precipitated with GST beads and analyzed by immunoblotting first with anti-myc antibody and later anti-His6 antibody. Ubiquitylated and non-ubiquitylated Kre22 proteins are indicated on the left of the panels. (C) The deletion of KRE22 does not alter DSK2-induced toxicity. The spotting assay was done as described in Figure 1A. The vector plasmid or plasmid bearing DSK2 regulated by the galactose-inducible GAL1 promoter was separately introduced into wild-type or kre22Delta cells as indicated. Exponentially growing yeast cells were spotted onto glucose-containing SD-ura (expression off) and galactose-containing SG-ura (expression on) media in serial five-fold dilutions. The strains used and the plasmid for DSK2 overexpression are labeled on the left of the panels. (D) overexpression of KRE22, but not two other proteasomal substrates RTA and UbV76-V-betagal, suppressed DSK2-trigged slow growth in wild-type cells. The spotting assay was done as described above. The expression of these substrates is also regulated by the GAL1 promoter. The identities of these substrates and the plasmid for DSK2 overexpression are listed to the left of the panels.
###end p 50
###begin p 51
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 251 256 251 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C, D</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 493 496 493 496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 649 652 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">V76</sup>
###xml 716 718 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
Among Ub-binding proteins involved in proteasome-mediated proteolysis, Dsk2 has the unique property that its overexpression caused toxicity [19,42]. We examined whether the deletion or overexpression of Kre22 could counteract overdose of Dsk2 (Figure 6C, D). Interestingly, increased expression of Kre22 partially suppressed Dsk2-induced toxicity (Figure 6D). We then asked whether other proteasomal substrates could keep Dsk2 in check. We employed RTA, a Rad23, but not Dsk2 substrate, and UbV76-Val-betagal that is regulated by both Rad23 and Dsk2. Interestingly, the suppression of Dsk2 is substrate specific since the overexpression of RTA or UbV76-Val-betagal could not overcome Dsk2-triggered toxicity (Figure 6D). YLL030C overexpression also partially suppressed Dsk2-induced growth retardation (data not shown)
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 779 781 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
We describe herein the use of a large-scale SDL screen as a new approach to identify proteolytic targets of the Rad23/Dsk2-dependent pathway. Although many strategies have been developed for substrate isolation, the identification of physiological targets of proteolytic pathways has proven to be quite challenging. For example, the first genetically defined Ub-dependent proteolytic pathway (i.e. N-end rule) was discovered in the mid-1980s [37,43]. Despite over a decade of intense efforts, the first cellular substrate of the N-end rule pathway was identified fortuitously. A key cell cycle protein, Scc1 is cleaved at the metaphase-anaphase transition [44] and the resulting carboxyl-terminal fragment is destroyed by the N-end rule pathway to maintain chromosome stability [24]. Interestingly, overexpression of Scc1 leads to lethality in mutant cells lacking the N-end rule E3 enzyme (Figure 1A, and reference [24]). This finding highlights the difficulty in obtaining proteolytic substrates and also suggests that an SDL screen could be effective for substrate identification.
###end p 53
###begin p 54
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 462 469 462 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 547 551 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1</italic>
###xml 834 835 834 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 892 893 892 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 894 895 894 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 896 898 896 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1064 1065 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1290 1291 1290 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1294 1295 1294 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 650 655 <span type="species:ncbi:4932">yeast</span>
An SDL approach was first employed to uncover genetic interactions in DNA replication or chromosome segregation [32,33]. More recently, it was demonstrated that SDL screens could be used to identify novel targets of a protein kinase (i.e. Pho85) [28]. Our study further extends the effectiveness of the SDL screen to the Ub/proteasome system. The advantages of SDL as a screening tool for proteolytic substrate identification include that the assay is performed in vivo, and the protein expression levels are enhanced by the strong promoter (i.e. GAL1). Like other approaches for target discovery, SDL screens have limitations. Of approximately 5000 yeast genes we screened, only two Dsk2 substrates were isolated. Several factors may contribute to the high false negative level: 1) redundancy of various substrate delivery pathways [7,8,23]. Several known Dsk2/Rad23 substrates (e.g. Sic1) [7,8,23] were not recovered in this screen. In the absence of Dsk2/Rad23, other Ub adaptor molecules (e.g. Rpn10, Cdc48, Ddi1, Rpn13) may maintain sufficient proteolysis [7,8]; 2) genes that lead to severe growth defects in wild-type cells with increased dosage are likely to be excluded from such analysis; 3) not all substrates would elicit enhanced fitness defects in proteolysis mutants (Figure 1); 4) the screen is an indirect way for target discovery. Large number of false positives, partly due to a low colony size cutoff, may mask some true positives; 5) screening strategy and criteria for target identification may need further refinement. For example, the rapid turnover or absence of particular substrates might be a requirement under very specific environmental or physiological conditions, which were not covered by our standardized screening protocol (e.g. degradation of nuclear-specific Far1 in response to mating pheromone). Nevertheless, given the difficulty involved in substrate isolation, we believe that SDL provides another way to delineate the functional relationship between a substrate and the specific degradation pathway.
###end p 54
###begin p 55
###xml 147 158 147 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A, C, E, G</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
To our knowledge, GST-Kre22 is the first substrate that requires only Dsk2, but not other Ub receptors (e.g. Rpn10, Rad23) for degradation (Figure 5A, C, E, G). Interestingly, overexpressed Kre22 but not other proteasomal substrates suppresses Dsk2-induced toxicity (Figure 6D). Although the precise mechanism underlying the Dsk2-triggered toxic effect is not clear [42], one possible explanation is that excessive Dsk2 may engage in the abnormal activities that interfere with cell growth. And increased amount of specific substrates may keep Dsk2 in check. Our results suggest that Kre22 could serve as an important tool to understand the Dsk2-dependent proteolysis.
###end p 55
###begin p 56
###xml 208 219 208 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 779 790 779 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
###xml 980 988 980 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1082 1084 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
Most proteins identified are not direct proteolytic substrates of Rad23 and Dsk2. This is not unexpected since other genes that function in the linear pathway of Rad23/Dsk2 target may also induce toxicity in rad23 dsk2 mutant cells upon their overexpression. For example, in a separate study on the function of Rad23 and Dsk2, we identified a cell cycle protein involved in the spindle pole body (SPB) duplication as a degradation target of Rad23 and Dsk2 (C.L., H.R., unpublished results). Interestingly, this protein is known to act upstream of Spc98, a component of the SPB [41]. It is likely that increased levels of Spc98 mimic the accumulation of this Rad23/Dsk2 target involved in spindle regulation to affect SPB duplication, which in turn triggers growth retardation in rad23 dsk2 mutant cells. Therefore, although the other eight proteins identified by our screen are not regulated directly by Rad23 and Dsk2, we suspect that these proteins work with Rad23/Dsk2 targets in vivo and cellular responses to their overexpression require the function of Rad23 and Dsk2 (Figure 2B).
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 317 328 317 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rad23 dsk2 </italic>
In conclusion, as proof-of-concept, we show that an SDL screen offers an effective, complementary method to elucidating biological functions of proteolytic pathways. Dsk2 was first identified 11 years ago in a genetic screen for genes involved in SPB duplication [19]. To our knowledge, the Spc98-induced toxicity in rad23 dsk2 mutant cells is the second piece of evidence linking Dsk2 and Rad23 to SPB duplication, which will help us to unravel the specific role of Rad23 and Dsk2 in this process. It is also conceivable that the SDL screen can be adapted to identify relevant ubiquitylation enzymes involved in substrate turnover. The creation of RNAi knock-down libraries and ORF overexpression collections would extend the use of SDL screens in the Ub/proteasome system to higher eukaryotes.
###end p 58
###begin title 59
Abbreviations
###end title 59
###begin p 60
###xml 44 46 44 46 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ub</underline>
###xml 54 55 54 55 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 71 73 71 73 <underline xmlns:xlink="http://www.w3.org/1999/xlink">ub</underline>
###xml 81 82 81 82 <underline xmlns:xlink="http://www.w3.org/1999/xlink">l</underline>
###xml 92 93 92 93 <underline xmlns:xlink="http://www.w3.org/1999/xlink">s</underline>
###xml 102 103 102 103 <underline xmlns:xlink="http://www.w3.org/1999/xlink">d</underline>
###xml 109 110 109 110 <underline xmlns:xlink="http://www.w3.org/1999/xlink">l</underline>
###xml 146 147 146 147 <underline xmlns:xlink="http://www.w3.org/1999/xlink">g</underline>
###xml 158 159 158 159 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 159 160 159 160 <underline xmlns:xlink="http://www.w3.org/1999/xlink">t</underline>
SPB: spindle pole body; Ub: ubiquitin; UBA: ubiquitin-associated; UBL: ubiquitin-like; SDL: synthetic dosage lethality; His6: hexahistidine; GST: glutathione Stransferase.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
CL, DvD and YL performed the experiments. BA and HR conceived the study and designed the experiments. CL, DvD, BA and HR wrote the manuscript.
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
We thank the members of the Rao laboratory, especially Ikjin Kim, for stimulating discussions. The authors thank Drs. Charlie Boone and Michael Costanzo for providing the SGA strain used to generate the double mutant for the SDL screen. HR is supported by the National Institutes of Health (GM078085). BA is supported by grants from the Canadian Institutes of Health Research (CIHR) and from Genome Canada through the Ontario Genomics Institute, and DvD is the recipient of a Fellowship from the Best Foundation.
###end p 64
###begin article-title 65
The proteasome, a novel protease regulated by multiple mechanisms
###end article-title 65
###begin article-title 66
Recognition and processing of ubiquitin-protein conjugates by the proteasome
###end article-title 66
###begin article-title 67
Modification of proteins by ubiquitin and ubiquitin-like proteins
###end article-title 67
###begin article-title 68
###xml 27 38 <span type="species:ncbi:71232">wallflowers</span>
Rad23 and Rpn10: perennial wallflowers join the melee
###end article-title 68
###begin article-title 69
Delivery of ubiquitinated substrates to protein-unfolding machines
###end article-title 69
###begin article-title 70
What's Ub chain linkage got to do with it?
###end article-title 70
###begin article-title 71
Multiubiquitin Chain Receptors Define a Layer of Substrate Selectivity in the Ubiquitin-Proteasome System
###end article-title 71
###begin article-title 72
A series of ubiquitin binding factors connects CDC48/p97 to substrate multiubiquitylation and proteasomal targeting
###end article-title 72
###begin article-title 73
Membrane and soluble substrates of the Doa10 ubiquitin ligase are degraded by distinct pathways
###end article-title 73
###begin article-title 74
UBA domains of DNA damage-inducible proteins interact with ubiquitin
###end article-title 74
###begin article-title 75
Proteins containing the UBA domain are able to bind to multi- ubiquitin chains
###end article-title 75
###begin article-title 76
Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23
###end article-title 76
###begin article-title 77
Rad23 links DNA repair to the ubiquitin/proteasome pathway
###end article-title 77
###begin article-title 78
Proteasome subunit Rpn1 binds ubiquitin-like protein domains
###end article-title 78
###begin article-title 79
###xml 93 117 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Pleiotropic defects caused by loss of the proteasome- interacting factors Rad23 and Rpn10 of Saccharomyces cerevisiae
###end article-title 79
###begin article-title 80
A genomic screen identifies Dsk2p and Rad23p as essential components of ER-associated degradation
###end article-title 80
###begin article-title 81
Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors
###end article-title 81
###begin article-title 82
Involvement of the DNA repair protein hHR23 in p53 degradation
###end article-title 82
###begin article-title 83
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center
###end article-title 83
###begin article-title 84
Multiple interactions of rad23 suggest a mechanism for ubiquitylated substrate delivery important in proteolysis
###end article-title 84
###begin article-title 85
Ubiquitin docking at the proteasome through a novel pleckstrin-homology domain interaction
###end article-title 85
###begin article-title 86
Analysis of polyubiquitin conjugates reveals that the Rpn10 substrate receptor contributes to the turnover of multiple proteasome targets
###end article-title 86
###begin article-title 87
Quantitative profiling of ubiquitylated proteins reveals proteasome substrates and the substrate repertoire influenced by the Rpn10 receptor pathway
###end article-title 87
###begin article-title 88
Degradation of a cohesin subunit by the N-end rule pathway is essential for chromosome stability
###end article-title 88
###begin article-title 89
A Proteolytic Pathway That Recognizes Ubiquitin as a Degradation Signal
###end article-title 89
###begin article-title 90
The Png1-Rad23 complex regulates glycoprotein turnover
###end article-title 90
###begin article-title 91
Global analysis of protein activities using proteome chips
###end article-title 91
###begin article-title 92
Mapping pathways and phenotypes by systematic gene overexpression
###end article-title 92
###begin article-title 93
###xml 22 27 <span type="species:ncbi:4932">yeast</span>
Global mapping of the yeast genetic interaction network
###end article-title 93
###begin article-title 94
###xml 35 40 <span type="species:ncbi:4932">yeast</span>
###xml 41 65 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Proteasome inhibition in wild-type yeast Saccharomyces cerevisiae cells
###end article-title 94
###begin article-title 95
Establishing genetic interactions by a synthetic dosage lethality phenotype
###end article-title 95
###begin article-title 96
###xml 49 54 <span type="species:ncbi:4932">yeast</span>
Exploring genetic interactions and networks with yeast
###end article-title 96
###begin article-title 97
###xml 111 116 <span type="species:ncbi:4932">yeast</span>
Phosphorylation- and ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor Far1p in budding yeast
###end article-title 97
###begin article-title 98
###xml 98 103 <span type="species:ncbi:4932">yeast</span>
Genes involved in sister chromatid separation are needed for B-type cyclin proteolysis in budding yeast
###end article-title 98
###begin article-title 99
The recognition component of the N-end rule pathway
###end article-title 99
###begin article-title 100
In vivo half-life of a protein is a function of its amino-terminal residue
###end article-title 100
###begin article-title 101
###xml 73 78 <span type="species:ncbi:4932">yeast</span>
###xml 79 103 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Systematic identification of the genes affecting glycogen storage in the yeast Saccharomyces cerevisiae: implication of the vacuole as a determinant of glycogen level
###end article-title 101
###begin article-title 102
###xml 58 82 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae
###end article-title 102
###begin article-title 103
A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage
###end article-title 103
###begin article-title 104
###xml 86 110 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The spindle pole body component Spc98p interacts with the gamma-tubulin-like Tub4p of Saccharomyces cerevisiae at the sites of microtubule attachment
###end article-title 104
###begin article-title 105
Extraproteasomal Rpn10 restricts access of the polyubiquitin-binding protein Dsk2 to proteasome
###end article-title 105
###begin article-title 106
Regulated protein degradation
###end article-title 106
###begin article-title 107
Sister-chromatid separation at anaphase onset is promoted by cleavage of the cohesin subunit Scc1
###end article-title 107

